Reducing body myopathy associated with the LIM2 p.(His123Arg) FHL1 variant

Leila Darki, Arash Jalali-Sohi, Samuel Guzman, Anna J. Mathew, Robert C. Bucelli, Kyle M. Hurth, Said R. Beydoun

Research output: Contribution to journalArticlepeer-review


Reducing body myopathy (RBM) is a rare muscle disorder, with marked presence of characteristic intracytoplasmic aggregates in affected muscle fibers. RBM is associated with FHL1 gene mutations. Clinical presentations of RBM have ranged from early fatal to adult onset progressive muscle weakness. We present herein the clinical, electrodiagnostic, and muscle biopsy findings of a 17-year-old female with progressive muscle weakness and contracture. Muscle biopsy showed atrophic fibers that contained menadione nitroblue tetrazolium (NBT) positive reducing bodies. Genetic testing revealed a variant of uncertain significance in the FHL1 gene at a position known to be pathogenic when substituted by other amino acids (p.His123Arg). This variant was later reclassified as pathogenic.

Original languageEnglish
Article number106795
JournalClinical Neurology and Neurosurgery
StatePublished - Aug 2021


  • FHL1
  • Muscle weakness
  • Myopathy
  • RBM
  • Reducing body


Dive into the research topics of 'Reducing body myopathy associated with the LIM2 p.(His123Arg) FHL1 variant'. Together they form a unique fingerprint.

Cite this